Source: Eur Respir Rev, 27 (148) 180017; 10.1183/16000617.0017-2018
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Dhiren F. Patel, Robert J. Snelgrove. The multifaceted roles of the matrikine Pro-Gly-Pro in pulmonary health and disease. Eur Respir Rev, 27 (148) 180017; 10.1183/16000617.0017-2018

Member's Comments

No comment yet.

Related content which might interest you: The role anti-inflammatory cytokines in pathogenesis professional occupetional pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 122s Year: 2003 Early life influences on the development of chronic pulmonary diseases: the role of the paediatrician Source: Virtual Congress 2020 – Chronic respiratory diseases and their origins in early life: how physiology meets clinical medicine Year: 2020 The pivotal role of nurses in educating patients with pulmonary hypertension Source: Annual Congress 2008 - Future management of pulmonary arterial hypertension Year: 2008 The potential role of antimicrobial peptides from wasp as regulators of the fibrotic process in idiopathic pulmonary fibrosis. Source: International Congress 2019 – Assessment and management of immune-mediated interstitial lung diseases Year: 2019 Enablers, barriers, needs and preferences of physical activity in patients with COPD: does pulmonary rehabilitation play a role? Source: International Congress 2019 – Exercise and rehabilitation in patients with acute and chronic respiratory diseases Year: 2019 Revisiting the role of pulmonary surfactant in chronic inflammatory lung diseases and environmental exposure Source: Eur Respir Rev, 30 (162) 210077; 10.1183/16000617.0077-2021 Year: 2021 The emerging role of epigenetics in pulmonary hypertension Source: Eur Respir J 2016; 48: 903-917 Year: 2016 Asthma and pulmonary arterial hypertension: do they share a key mechanism of pathogenesis? Source: Eur Respir J 2010; 35: 730-734 Year: 2010 Can soluble CD-163 be related to disease activity in pulmonary sarcoidosis? Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010 Identifying pulmonary hypertension in newly recognized interstitial lung diseases – a role of new scoring system Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Pro-inflammatory cytokines in pathogenesis professional occupetional pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 148s Year: 2004 The role of pulmonary rehabilitation in the prevention of exacerbations of chronic lung diseases Source: Eur Respir Monogr 2017; 77: 224-246 Year: 2017 IL-36? – a key mediator of neutrophilic inflammation in chronic obstructive pulmonary disease Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease Year: 2021 WHO actions to promote lung health Source: Research Seminar 2013 - ERS Presidential Summit on Research gaps, patient needs and innovative solutions: a forward look on lung health research Year: 2013 Disease-specific inflammatory environments induce different anti-inflammatory MSC actions that play critical roles in mitigating lung injury Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Regulation of inflammation process in chronic thromboembolic pulmonary hypertension: a potential role of platelet-activating factor-acetylhydrolase Source: Annual Congress 2006 - Pulmonary circulation: inflammation and remodelling Year: 2006 The role of pathological angiogenesis in the pathogenesis of the chronic inflammatory lung diseases Source: Annual Congress 2005 - Update on the role of angiogenesis in the pathogenesis and treatment of lung diseases Year: 2005 Impact of pulmonary vascular volume on mortality in IPF: is it time to reconsider the role of vasculature in disease pathogenesis and progression? Source: Eur Respir J , 49 (2) 1602524; DOI: 10.1183/13993003.02524-2016 Year: 2017 Impact of pulmonary vascular volume on mortality in IPF: is it time to reconsider the role of vasculature in disease pathogenesis and progression? Source: Eur Respir J , 49 (2) 1602345; DOI: 10.1183/13993003.02345-2016 Year: 2017